Chronic airway infections by the opportunistic pathogen Pseudomonas aeruginosa are major cause of 2 mortality in cystic fibrosis (CF) patients. While this bacterium has been extensively studied for its 3 virulence mechanisms, biofilm growth and immune evasion within the CF airways, comparatively little is 4 known about the nutrient sources that sustain its growth in vivo. Respiratory mucins represent a 5 potentially abundant bioavailable nutrient source, though we have recently shown that canonical 6 pathogens inefficiently use these host glycoproteins as a growth substrate. Yet, given that P. aeruginosa, 7 particularly in its biofilm mode of growth is thought to grow slowly in vivo, the inefficient use of mucin 8 glycoproteins may have relevance to its persistence within the CF airways. To this end, here we use 9 whole genome fitness analysis combining transposon mutagenesis with high throughput sequencing 10 (TnSeq) to identify genetic determinants required for P. aeruginosa growth using intact purified mucins 11 as a sole carbon source. Our analysis reveals a biphasic growth phenotype, during which the glyoxylate 12 pathway and amino acid biosynthetic machinery are required for mucin utilization. Secondary analyses 13 confirmed the simultaneous liberation and consumption of acetate during mucin degradation and 14 revealed a central role for the extracellular proteases LasB and AprA. Together, these studies identified 15 the P. aeruginosa genes required for mucin-based nutrient acquisition and reveal a host-pathogen 16 dynamic that may contribute to its persistence within the CF airways.
INTRODUCTION
1 fact, all mucosal sites throughout the human body harbor both commensal and pathogenic organisms 2 that possess mucin-degrading enzymes capable of deriving nutrients from host (22-24). Indeed, several 3 studies have described the degradation and utilization of mucins by CF-associated microbiota (25-29).
4
For example, multiple studies have shown that P. aeruginosa and other pathogens (e.g. Burkholderia 5 cepecia complex, Bcc) harbor mucin sulfatase activity capable of utilizing sialylated mucin 6 oligosaccharides as a source of sulfur (26, 28) . Others have shown that Bcc isolates possess mucinase 7 activity that can sustain pathogen growth using mucins as a sole carbon source (29). These studies 8 emphasize the potential importance of mucins as a growth substrate for the initiation and maintenance of 9 CF infections in vivo.
10
To investigate respiratory mucin-bacterial interactions in further detail, artificial sputum media 11 (ASM) is commonly used to mimic the in vivo nutritional environment of the diseased airways. Among its 1 modified mariner transposon (41) was further modified to replace the kanamycin resistance cassette with 2 a gentamicin cassette for use in P. aeruginosa. Briefly, the plasmid containing the transposon and 3 transposase (pEB001)(40) was used as template in a PCR using TnSwap1 and TnSwap2 (a list of 4 primers is shown in Table S1 ) to generate a fragment containing the whole pEB001 plasmid lacking a 5 selectable marker. Next, the gene encoding gentamicin acetyltransferase (gent R ) was amplified from 6 pBBR1MCS-5 (42) using GentR_Fwd and GentR_Rev primers. Gibson assembly (43) was used to 7 combine gent R with the linearized pEB001 plasmid generated by PCR above to create pJF1. Next, pJF1 8 was transformed into the conjugative mating strain WM3064 (39) and a saturating transposon mutant 9 library was generated by mating P. aeruginosa PA14 with WM3064 (containing pJF1) on LB + DAP agar 10 plates followed by selection on LB gentamicin (50 µg mL -1 ). Mutants (~70,000) were pooled en masse in 11 LB + 15% glycerol and were frozen in 100µL aliquots.
12
Outgrowth experiments are described in Figure 2 . Briefly, one 100 µL aliquot was pelleted and 13 frozen for gDNA extraction ("Parent"). A second glycerol stock was thawed, washed twice in PBS before 14 inoculation into 5mL of MMM to an OD 600 of 0.02. Cultures were shaken at 250 RPM at 37°C and OD 600 15 was monitored until the cells reached ~0.4. 0.25mL of this culture was then used to inoculate a fresh 16 5mL of MMM and allowed to grow to ~0.4 (representing approximately 10 doublings, "1 st Phase"). A 17 second culture was prepared by inoculating an additional 100µL glycerol stock into filter-sterilized spent 18 growth medium from the 1 st phase, followed by outgrowth to ~0.4 OD. As described above, 0.25mL was 19 used to inoculate a fresh 5mL of spent medium and allowed to grow again to ~0.4 (~10 doublings, "2 nd 20 phase"). Bacterial cells were harvested by centrifugation and frozen at -80°C.
21
Genomic DNA (gDNA) was extracted from frozen cell pellets using the Wizard Genomic DNA Purification Kit (Promega), cut with MmeI restriction enzyme (New England Biolabs) and treated with calf 23 intestinal phosphatase (New England Biolabs). Oligonucleotide adapters (Table S1 ) with a 3'-NN 24 overhang containing appropriate sequences for Illumina sequencing were ligated to the resulting 7 to enable multiplexing. PCR was then performed using ligation reactions as template with primers 1 specific for the inverted repeat region on the transposon and the ligated adapter (P1_M6_MmeI and 2 Gex_PCR_Primer, respectively). These primers introduce sequences suitable for direct sequencing in an The resulting sequence was mapped to the PA14 genome (Genbank GCA_000014625.1) using Bowtie, 9 discarding reads with greater than 1bp mismatch and sequences mapping to multiple locations.
10
Insertions within the first 5% and last 10% of the open reading frame were also discarded to provide 11 greater assurance that the insertion resulted in a null mutation. With these parameters, the Parent, 1 st 12 phase, and 2 nd phase had 27 million, 17 million, and 10 million total mapped hits, respectively. Genes 13 with fewer than 10 unique insertions in the parent library were removed from analysis to limit their 14 associated variability. Fitness values for each gene were then scored by computing a hit-normalized fold 15 change for each growth condition (log 2 (outgrowth library hits / parent library hits)). This calculation 16 identifies the fold-change in transposon mutant abundance between the parent and outgrowth 17 populations (i.e. for a gene with a score of -2, there were 4X the number of cells containing a mutation in 18 the parent library compared to the outgrowth). Negative fold-changes signified mutations with fitness 19 defects under the outgrowth condition.
20
Genetic manipulation. In-frame, markerless deletions in PA14 were generated using established 21 homologous recombination techniques. Plasmids (Table 1) were derived from the suicide vector pSMV8 (39) and manipulated using standard molecular biology protocols with E. coli DH5α (UQ950). For 23 deletion constructs, 1000 bp regions flanking the gene to be deleted (including 3-6 codons of the 24 beginning and end of the genes) were amplified by PCR using primers listed in Table S1 . Fragments were amplified by PCR using gene specific primers (Table S1 ). Resulting fragments were gel-purified 5 and digested using the restriction enzymes KpnI, SacI, and XhoI where appropriate. After digestion, 6 purified fragments were combined with digested pBBR1MCS-5, ligated using T4 ligase and transformed 7 into UQ950. Positive transformants were screened by PCR and confirmed by sequencing.
8
Complementation constructs were mated into PA14 via conjugation using WM3064 as described above.
9
Successful matings were selected for by plating on LB agar containing gentamicin. All constructs and 10 deletions were verified by sequencing. 11 12 RESULTS prepared by autoclaving followed by dialysis to remove low molecular weight metabolites. This ensured in 10 g L -1 undialyzed mucins; however, when PGM was dialyzed, density fell to 0.25 ( Fig 1A) . These 18 data suggest that over half of the bioavailable nutrients for PA14 in the undialyzed mucin preparation 19 were composed of small metabolites.
20
To facilitate the study of P. aeruginosa growth on intact mucins, we then increased the PGM 21 content in the culture medium to 30 g L -1 , well above physiological concentrations. Under these 22 conditions, a biphasic growth pattern was observed. Growth up to 0.35 OD ("1 st Phase") proceeded with 23 a doubling time approximately 2X that of growth from 0.35 to 0.8 ("2 nd phase")( Fig. 1B ), which reached its 24 peak cell density after 11 hours. To determine if there was an unfulfilled nutrient requirement that limited 25 P. aeruginosa growth in either growth phase, we then grew PA14 on PGM with and without supplements supplement stimulated an increase in cell density, suggesting that the limiting nutrient of our minimal 1 mucin medium (MMM) was likely carbon.
2
To assess the efficiency of PA14 to utilize PGM relative to other carbon sources (e.g., the 3 constituent amino acids and sugars in mucin glycoproteins), we then compared growth yields of PA14 4 when grown on glucose, casamino acids (CasAA), and PGM alone (Fig. 1C) . On a gram-per-OD basis, 5 PA14 obtained ~25X the density using glucose and ~100X the density using CasAA relative to dialyzed 6 mucin (1.28, 0.3, and 34 g L -1 OD -1 for glucose, CasAA, and mucin, respectively). This limited growth 7 yield of PA14 on mucins relative to other carbon sources underscores the inefficient use of intact mucin 8 glycoproteins by P. aeruginosa. 9 10 TnSeq reveals a need for glyoxylate bypass in mucin utilization. Despite the inefficient growth of P. 11 aeruginosa on mucins, any breakdown and metabolism of these glycoproteins may be relevant to 12 pathogen growth and persistence within the CF airways. Therefore, we sought to determine the 13 mechanisms by which PA14 utilizes intact mucins in the absence of a complex, mucin-degrading 14 bacterial community (34). To do so, we used a high-throughput transposon insertion sequencing 15 approach, TnSeq, to identify the genetic requirements for P. aeruginosa throughout its biphasic growth 16 phenotype described in Fig. 2B . This method allows for a comprehensive, single-culture mutant screen 17 using a pooled transposon library, outgrowth of that library under a set of selective conditions, followed 18 by Illumina sequencing to provide a semi-quantitative measure of fitness for each gene. Using the 19 sequencing output, a fitness score for transposon insertions at each genetic locus can be calculated. We 20 applied this technique to study PA14 growth under selection in the first (rapid) growth phase, and the 21 second (slow) growth phase for ~10 generations each.
Our experimental approach is shown in Fig. 2 . A library of ~70,000 transposon mutants were 23 isolated on LB agar plates, pooled, and frozen. To perform the selection experiments, an aliquot was 24 thawed and used to inoculate the MMM growth medium, and the remaining culture was then pelleted and 25 frozen for genomic DNA isolation. Two medium conditions were then tested for selection: (i) dialyzed a growth defect. For example, PA14 did not require any specific amino acid biosynthetic genes, 1 suggesting that a complete mix of amino acids were liberated from mucins and were available as 2 'community goods'. Under these conditions, transposon insertions that would otherwise result in a 3 growth-inhibited phenotype for an auxotophic mutant in pure culture might not confer a defect in a 4 community of pooled transposon mutants with mixed abilities. Given the lack of amino acid biosynthetic 5 genes required for the second growth phase, we hypothesized that amino acids were being liberated 6 from mucins and serving as the primary source of carbon and energy. 7 8 PA14 liberates and consumes acetate in the first phase of growth and consumes amino acids 9 throughout growth. Given the requirement for the glyoxylate pathway, we hypothesized that acetate 10 may be liberated from mucin. To assess this, we monitored acetate concentrations in the medium 11 throughout growth. Though no acetate was initially present in the growth medium, it rapidly accumulated 12 in the culture supernatant during the first growth phase (Fig. 3A) . Its concentration increased until the 13 transition between the first and second growth phase (~0.3 OD), where it was rapidly consumed. This 14 result is consistent with the glyoxylate pathway being required for the first growth phase in which 2-15 carbon compounds serve as a primary carbon source.
16
Given that no amino acid biosynthetic genes were essential in the second growth phase, we 17 predicted that amino acids were liberated via degradation of the mucin glycoprotein. We therefore 18 quantified protein content (excluding free amino acids) in the medium supernatant ( Figure 3B ).
19
Interestingly, protein concentration remained unchanged in the first phase of growth, and rapidly declined 20 in the second phase. Taken together, these observations demonstrate a sequential use of carbon 21 sources (acetate, followed by amino acids) derived from the mucin glycoprotein.
23
Growth of aceA, lasB and aprA mutants demonstrate growth defects in PGM. To confirm the 24 importance of acetate and the glyoxylate pathway in the first phase of growth, a non-polar, markerless 25 deletion was made in aceA, encoding isocitrate lyase, which catalyzes the first step in the glyoxylate source because it would be unable to correctly balance carbon requirements in the TCA cycle.
1
Consistent with this limitation, the aceA mutant demonstrated a marked growth defect relative to WT and 2 reached a lower final density (Fig. 4A, Fig. S1 ). The incomplete abolishment of growth suggests that 3 the ΔaceA mutant is capable of obtaining carbon via other means but that the glyoxylate pathway defect 4 restricts its growth and overall yield.
5
Protein consumption in the second growth phase suggested that one or more extracellular 6 proteases were being employed to degrade the mucin polypeptide backbone. To address this possibility, 7 we tested four extracellular proteases (LasA, LasB, AprA and SppA) that may be important for the 8 degradation of extracellular peptides. Non-polar, markerless deletions were made in genes encoding 9 each of these proteases and their growth was assayed versus WT in MMM ( Fig. 4B,C) . Interestingly, 10 only mutants lacking LasB and AprA exhibited defects in the second phase of growth and lower final 11 densities, while complementation with lasB and aprA in trans was able to restore the WT phenotype (Fig. 12 S1). These data demonstrate that elastase (LasB) and alkaline protease (AprA) are used by P.
13 aeruginosa during slow growth on mucins to utilize the polypeptide backbone as a carbon source.
15

DISCUSSION
16
In contrast to Streptococcus, Akkermansia, Bacteroides and other bacterial genera that have an 17 extensive repertoire of enzymes devoted to catabolizing host-associated glycoproteins in the gut and oral 18 cavity (24, 47-50), the primary cystic fibrosis pathogen, P. aeruginosa, is not known to encode any 19 glycosidases used in the breakdown of respiratory mucins. Indeed, here we demonstrate that strain 20 PA14 uses intact mucins inefficiently compared to its carbohydrate and amino acid monomeric 21 constituents (glucose and amino acids). However, when purified and dialyzed mucins were provided at high concentrations, we observed a slow, biphasic growth of PA14 to an appreciable density. This 23 observation suggests that a even a partial breakdown of mucin glycoproteins may support the slow 24 growth (35) and persistence of P. aeruginosa in the CF airways. survey of mucin utilization strategies has provided a window into a potential mechanism of P. aeruginosa 1 growth within the lower airways. While growth on mucins was limited, our data demonstrate that mucin 2 degradation alone can support low densities of PA14, which may allow for bacterial persistence when 3 nutrients are scarce (e.g. early stages of disease). We concede that the portrait of in vivo pathogen 4 growth is never simple in a disease with an array of etiologies. It is likely that as airway infections evolve, Deletion vector for lasA This study pSMV8lasB
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